1. Volume 65, Issue 6, Pages 2335-2342 (June 2004)
Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS 
Rachel B. Fissell, Jennifer L. Bragg-Gresham, John D. Woods, Michel Jadoul, Brenda Gillespie, Sara A. Hedderwick, Hugh C. Rayner, Roger N. Greenwood, Takashi Akiba, Eric W. Young 
Kidney International 
Volume 65, Issue 6, Pages (June 2004)
DOI: /j x
Copyright © 2004 International Society of Nephrology Terms and Conditions

2. Figure 1
Variation in hepatitis C virus (HCV) prevalence by patient's time with end-stage renal disease (ESRD). The mean time on ESRD was 4.9years, with a standard deviation of 5.4years.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

3. Figure 2
Distribution of hepatitis C virus (HCV) prevalence by facility. Mean HCV prevalence was 13.5%, with a median of 10.5%. The percentage of facilities with an HCV prevalence of 0% to 5% was 26.6%.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

4. Figure 3
Distribution of hepatitis C virus (HCV) seroconversion rates by facility. In 55.6% of facilities, the mean seroconversion rate was 0 seroconversions per 100 patient-years.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions